These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37217408)

  • 41. Efficient silencing of endogenous microRNAs using artificial microRNAs in Arabidopsis thaliana.
    Eamens AL; Agius C; Smith NA; Waterhouse PM; Wang MB
    Mol Plant; 2011 Jan; 4(1):157-70. PubMed ID: 20943811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review.
    Chruścik A; Lam AK
    Exp Mol Pathol; 2015 Dec; 99(3):393-8. PubMed ID: 26321247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative Stress-Responsive MicroRNAs in Heart Injury.
    Kura B; Szeiffova Bacova B; Kalocayova B; Sykora M; Slezak J
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
    Levati L; Alvino E; Pagani E; Arcelli D; Caporaso P; Bondanza S; Di Leva G; Ferracin M; Volinia S; Bonmassar E; Croce CM; D'Atri S
    Int J Oncol; 2009 Aug; 35(2):393-400. PubMed ID: 19578755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases.
    Chhabra R; Dubey R; Saini N
    Mol Cancer; 2010 Sep; 9():232. PubMed ID: 20815877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes.
    Hsu SD; Chu CH; Tsou AP; Chen SJ; Chen HC; Hsu PW; Wong YH; Chen YH; Chen GH; Huang HD
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D165-9. PubMed ID: 18029362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Manipulating Pericyte Function with MicroRNAs.
    Vitiello M; Cathcart B; Caporali A; Meloni M
    Methods Mol Biol; 2021; 2235():139-153. PubMed ID: 33576975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TSCCA: A tensor sparse CCA method for detecting microRNA-gene patterns from multiple cancers.
    Min W; Chang TH; Zhang S; Wan X
    PLoS Comput Biol; 2021 Jun; 17(6):e1009044. PubMed ID: 34061840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing Anti-miR Pharmacology with miRNA Polysome Shift Assay.
    Androsavich JR
    Methods Mol Biol; 2017; 1517():103-113. PubMed ID: 27924477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis.
    Chen Z; Zhan Y; Chi J; Guo S; Zhong X; He A; Zheng J; Gong Y; Li X; Zhou L
    EBioMedicine; 2018 Aug; 34():94-107. PubMed ID: 30037718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer.
    Slaby O; Bienertova-Vasku J; Svoboda M; Vyzula R
    J Cell Mol Med; 2012 Jan; 16(1):8-21. PubMed ID: 21692980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNAs as therapeutic targets in human diseases.
    Jeyaseelan K; Herath WB; Armugam A
    Expert Opin Ther Targets; 2007 Aug; 11(8):1119-29. PubMed ID: 17665982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miRTRS: A Recommendation Algorithm for Predicting miRNA Targets.
    Jiang H; Wang J; Li M; Lan W; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(3):1032-1041. PubMed ID: 30281478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites.
    Gong W; Xiao D; Ming G; Yin J; Zhou H; Liu Z
    J Diabetes; 2014 Jul; 6(4):279-89. PubMed ID: 24606011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic Variants in MicroRNAs and Their Binding Sites Are Associated with the Risk of Parkinson Disease.
    Ghanbari M; Darweesh SK; de Looper HW; van Luijn MM; Hofman A; Ikram MA; Franco OH; Erkeland SJ; Dehghan A
    Hum Mutat; 2016 Mar; 37(3):292-300. PubMed ID: 26670097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vesicle-associated microRNAs are released from blood cells on incubation of blood samples.
    Köberle V; Kakoschky B; Ibrahim AA; Schmithals C; Peveling-Oberhag J; Zeuzem S; Kronenberger B; Waidmann O; Pleli T; Piiper A
    Transl Res; 2016 Mar; 169():40-6. PubMed ID: 26608461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential Inhibition of Target Gene Expression by Human microRNAs.
    Li P; Chen Y; Juma CA; Yang C; Huang J; Zhang X; Zeng Y
    Cells; 2019 Jul; 8(8):. PubMed ID: 31366019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity.
    Gurtner A; Falcone E; Garibaldi F; Piaggio G
    J Exp Clin Cancer Res; 2016 Mar; 35():45. PubMed ID: 26971015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNAs as ideal biomarkers for the diagnosis of lung cancer.
    Guo Z; Zhao C; Wang Z
    Tumour Biol; 2014 Oct; 35(10):10395-407. PubMed ID: 25053595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Global and local competition between exogenously introduced microRNAs and endogenously expressed microRNAs.
    Kim D; Kim J; Baek D
    Mol Cells; 2014 May; 37(5):412-7. PubMed ID: 24823356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.